Global Health Press

All Articles

GHP NewsLatest Science

Literature update ViVa week 17-2026

1. Multistage malaria shot shows mid-term protection in Malian adults – but transmission benefits still unproven In this randomized, double blind trial from peri urban Mali, 34 healthy adults (18–50 years) with...

29 April, 2026
16 min read
GHP NewsLatest Science

Why this history matters now

The story of early TBE research in the Soviet Union is more than a historical curiosity. It offers a vivid case study of how science, politics, and social conditions intertwine. It reminds us that medical breakthroughs...

29 April, 2026
5 min read
GHP NewsLatest Science

Vaccines and Vaccination (ViVa) news

Over roughly the past week, formal NITAG/agency outputs have largely reinforced and operationalized earlier 2026 policy decisions, while the most clearly “new” developments sit in World/Regional Immunization Week...

29 April, 2026
9 min read
GHP NewsLatest Science

Literature update ViVa week 16-2026

1. MF59-aQIV looks economically persuasive in Korea and Taiwan — but the price assumptions do a lot of the work This modelling study assessed the cost-effectiveness of MF59-adjuvanted quadrivalent influenza vaccine...

22 April, 2026
23 min read
GHP NewsLatest Science

ViVa 16 – NEWS around the globe

Global vaccination policy this week feels less like harmonized orchestration and more like controlled fragmentation—with a purpose. European and Western Pacific advisory groups are quietly locking in 2026–2027...

22 April, 2026
5 min read
GHP NewsLatest Science

Vaccines and vaccination news

Global WHO and public health WHO’s Technical Advisory Group on COVID-19 Vaccine Composition (TAG‑CO‑VAC) is preparing its next decision on updated COVID‑19 vaccine antigen composition, with a meeting scheduled for May...

14 April, 2026
4 min read